JW THERAP-B (02126.HK) Financial Statements - Balance Sheet/Income Statement/Cash Flow

Quote List Quote List

Event Tracking

Nov2

Yumeng Juno's CAR-T Cell Drug Aims for Inclusion in Commercial Insurance Innovative Drug Catalog

09:34

Oct21

JW Therapeutics Submits First-in-Human Phase I Data for Relmacabtagene Autoleucel

08:35

Oct9

JW Therapeutics' Relmacabtagene Ablamelical (Relma-Cel) Supplemental Application for Domestic Slow Virus Vector Approved for Filing by NMPA

09:00

Sep3

CICC Raises JUNO Therapeutics' Target Price to HKD 6.04

02:47

Aug27

JW THERAP-B released FY2025 Q1 earnings on August 27, 2025 (BJT) with actual revenue of HKD 56.95 M and EPS of HKD -0.3427

15:00

JW THERAP-B released FY2025 Semi-Annual Earnings on August 27 After-Market (BJT), actual revenue HKD 115.15 M, actual EPS HKD -0.6962

11:00

Schedules & Filings

Schedules

Filings

Aug27

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 58.2 M, Net Income -146.26 M, EPS -0.3519

Mar27

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 37.98 M, Net Income -186.36 M, EPS -0.4499

Aug28

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 46.64 M, Net Income -129.09 M, EPS -0.3124

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change